drugset / Trial / NCT06060977
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants
Non-randomizedSequentialOpen-labelTreatment
Summary
The primary objective of the study is to evaluate the safety of IMG-007 in adults with Alopecia Areata.
Timeline
- Start
- 2023-09-25
- Primary completion
- 2025-01-14
- Completion
- 2025-01-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IMG-007 | Unknown | 300 mg | Intravenous |
| Subject | IMG-007 | Unknown | 600 mg | Intravenous |